Press Releases

Date Title and Summary
Toggle Summary Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration
SUNNYVALE, Calif. , Nov. 1, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo ® C radiation therapy system for the Type B market has been submitted to the Chinese National Medical Products Administration
Toggle Summary Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member
Accuray Also Announces Chief Financial Officer, Ali Pervaiz SUNNYVALE, Calif. , April 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter , President, will succeed Joshua Levine as the company's Chief Executive Officer, effective July 1, 2022 .     Mr.
Toggle Summary Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023
SUNNYVALE, Calif. , June 15, 2023 /PRNewswire/ -- The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO Suzanne Winter has been recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology CEOs of 2023.
Toggle Summary Accuray Announces Results for Third Quarter of Fiscal 2011
SUNNYVALE, Calif., May 5, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2011, ended March 31, 2011 . For the third quarter of fiscal 2011, Accuray reported
Toggle Summary Accuray Announces Results for Third Quarter of Fiscal 2009
Record Total Revenue for Quarter SUNNYVALE, Calif ., May 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal 2009, ended March 28, 2009 .
Toggle Summary Accuray Announces Results for Third Quarter Fiscal 2013
New Order Activity Improves - First Installations of New Models - Guidance Updated SUNNYVALE, Calif. , May 7, 2013 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) today announced financial results for the third quarter of fiscal 2013 that ended March 31, 2013 .
Toggle Summary Accuray Announces Results for Third Quarter Fiscal 2012
Continued Service Margin Improvement Highlights Quarter SUNNYVALE, Calif. , May 8, 2012 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the third quarter of fiscal 2012 that ended March 31, 2012 .
Toggle Summary Accuray Announces Results for Third Quarter Fiscal 2010
14 Orders Added to Backlog Highlight Profitable Quarter SUNNYVALE, Calif., May 6, 2010 /PRNewswire via COMTEX/ --Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2010, ended March 31, 2010.
Toggle Summary Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
Click here for PDF version of this release 28 New Contracts Valued at $115.5 Million Signed in Fourth Quarter SUNNYVALE, Calif., Aug. 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth
Toggle Summary Accuray Announces Results for Second Quarter of Fiscal 2011
SUNNYVALE, Calif., Jan. 27, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010 . For the second quarter of fiscal 2011, Accuray

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.